Increased epicardial fat thickness is related with body mass index in women with polycystic ovary syndrome

被引:0
|
作者
Soydinc, E. [1 ]
Soydinc, S. [2 ]
Ariturk, Z. [2 ]
Tekbas, E. [2 ]
Cakici, M. [3 ]
Islamoglu, Y. [2 ]
Ercan, S. [3 ]
Sari, I. [3 ]
Davutoglu, V. [3 ]
机构
[1] Dicle Univ, Fac Med, Dept Obstet & Ginecol, Diyarbakir, Turkey
[2] Dicle Univ, Fac Med, Dept Cardiol, Diyarbakir, Turkey
[3] Gaziantep Univ, Fac Med, Dept Cardiol, Gaziantep, Turkey
关键词
Epicardial fat thickness; Polycystic ovary syndrome; Echocardiography; ADIPOSE-TISSUE; YOUNG-WOMEN; ECHOCARDIOGRAPHY; PARAMETERS; OBESITY; IMPACT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
AIM: We aimed to investigate the relationship between PCOS and epicardial fat thickness with transthoracic echocardiography. PATIENTS AND METHODS: PCOS patients were divided into two groups according to the lean or obesity status: PCOS patients with lean 34 subjects (BMI: 23.3+/-2.8; mean age: 25.5+/-4), PCOS patients with obese16 subjects (BMI: 32.3+/-7.6; mean age: 27.2+/-3.7) were compared with control healthy lean subjects (BMI: 23.5+/-1.7; mean age: 25.9+/-2.2). RESULTS: There was increased epicardial thickness in obese PCOS subjects compared to lean PCOS subjects (6.3+/-0.9 mm, 4.7+/-0.5, respectively, p < 0.001). However, epicardial fat thickness between lean PCOS subjects and lean healthy control groups were not significantly varied (4.7+/-0.5 mm, 4.5+/-0.5, respectively, p = 0.6). There was increased epicardial thickness in obese PCOS subjects compared to lean healthy control subjects (6.3+/-0.9 mm, 4.5+/-0.5, respectively, p < 0.001). This sudy showed for the first time that increased epicardial fat thickness measured using transthoracic echocardiography is associated with increased BMI in PCOS subjects. CONCLUSIONS: Epicardial fat thickness between lean PCOS subjects and lean healty control group were similar which indicate the importance of obesity in PCOS subjects.
引用
收藏
页码:2111 / 2113
页数:3
相关论文
共 50 条
  • [41] Comparison of body mass index and metabolic parameters with serum vaspin levels in women with polycystic ovary syndrome
    Dogan, Keziban
    Helvacioglu, Caglar
    Baghaki, Sema
    Ekin, Murat
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (02) : 137 - 139
  • [42] Correlations between dietary intake or body mass index and serum androgen in women with polycystic ovary syndrome
    Wang, Ting-Wen
    Chao, Jane C-J
    Wei, Hsiao-Jui
    Young, Robert
    Liaw, Chian-Mey
    Wang, Szu-Shun
    Jiang, Bo-Shu
    Ho, Hsin-Jung
    FASEB JOURNAL, 2010, 24
  • [43] Evaluation of common mental disorders in women with polycystic ovary syndrome and its relationship with body mass index
    Gomes Rodrigues, Cristine Eliane
    Ferreira, Luana de Lima
    Jansen, Karen
    Acosta Lopez, Mariane Ricardo
    Drews Junior, Claudio Raul
    de Mattos Souza, Luciano Dias
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2010, 34 (10): : 442 - 446
  • [44] Metformin doses and body mass index: clinical outcomes in insulin resistant polycystic ovary syndrome women
    Morgante, G.
    Massaro, M. G.
    Scolaro, V
    Cappelli, V
    Luddi, A.
    Troia, L.
    De Leo, V
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (15) : 8136 - 8142
  • [45] Associations of acanthosis nigricans with metabolic abnormalities in polycystic ovary syndrome women with normal body mass index
    Dong, Zhe
    Huang, Jia
    Huang, Lili
    Chen, Xiaoli
    Yin, Qianqian
    Yang, Dongzi
    JOURNAL OF DERMATOLOGY, 2013, 40 (03): : 188 - 192
  • [46] Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index
    Jedel, E.
    Waern, M.
    Gustafson, D.
    Landen, M.
    Eriksson, E.
    Holm, G.
    Nilsson, L.
    Lind, A. -K.
    Janson, P. O.
    Stener-Victorin, E.
    HUMAN REPRODUCTION, 2010, 25 (02) : 450 - 456
  • [47] Anandamide is associated with waist-to-hip ratio but not with Body Mass Index in women with polycystic ovary syndrome
    Kabakchieva, Plamena
    Gateva, Antoaneta
    Velikova, Tsvetelina
    Georgiev, Tsvetoslav
    Kamenov, Zdravko
    MINERVA ENDOCRINOLOGY, 2023, 48 (02): : 150 - 159
  • [48] Body fat patterning in polycystic ovary syndrome women as a predictor of the response to clomiphene
    Douchi, T
    Oki, T
    Yamasaki, H
    Nakae, M
    Imabayashi, A
    Nagata, Y
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2004, 83 (09) : 838 - 841
  • [49] Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome
    Kort, Daniel H.
    Kostolias, Alessandra
    Sullivan, Chantae
    Lobo, Roger A.
    GYNECOLOGICAL ENDOCRINOLOGY, 2015, 31 (02) : 152 - 155
  • [50] There are differences in the correlations between fat distribution and hemostatic parameters in women with polycystic ovary syndrome and healthy controls matched for age and body mass index
    Mendonca-Louzeiro, Maria
    Annichino-Bizzacchi, Joyce
    Benetti-Pinto, Cristina
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 124 - 124